Positron Corp POSC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.64
- Day Range
- $1.63–1.72
- 52-Week Range
- $1.27–2.74
- Bid/Ask
- $1.63 / $1.70
- Shares Outstanding
- 32.85M
- Market Cap
- $53.54M
- Volume/Avg
- 5,479 / 17,606
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 117.93
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Positron Corp is a medical technology company engaged in the co-development, manufacture, and sale of PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. By combining proprietary PET and PET-CT systems with comprehensive clinical and technical support, flexible financing, & a focus on operational efficiency, Positron makes advance diagnostic imaging more accessible & sustainable for hospitals, outpatient centers, & physician practices. The company focused on advancing positron emission tomography imaging through the development, manufacture, & commercialization of PET & PET-computed tomography imaging systems.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 10
- Website
- https://www.positron.com
Valuation
|
Metric
|
POSC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 117.93 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
POSC
|
|---|---|
Quick Ratio | 0.17 |
Current Ratio | 0.49 |
Interest Coverage | −94.97 |
Quick Ratio
POSC
Profitability
|
Metric
|
POSC
|
|---|---|
Return on Assets (Normalized) | −355.08% |
Return on Equity (Normalized) | −3,206.40% |
Return on Invested Capital (Normalized) | −491.69% |
Return on Assets
POSC
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|&V!m#z | LOCK|yz$@< | $177B | |||
| Medtronic PLC
MDT
| LOCK|qfvx!<^ | LOCK|VmjV? | $124B | |||
| Stryker Corp
SYK
| LOCK|&&w#Vkt$ | LOCK|J#^ | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|Y^^&#Y | LOCK|^mHR@ | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|?^C#><X | LOCK|#g<p | $52B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Y#YXb$< | LOCK|^L | $32B | |||
| DexCom Inc
DXCM
| LOCK|@%nRV>? | LOCK|SP#Z? | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|<h# | LOCK|@Y@ | $26B | |||
| Steris PLC
STE
| LOCK|<ZV^kW | LOCK|pK<W | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|@Z#L?L^L | LOCK|rSV | $19B |
United States